FIELD: medicine, pediatrics. SUBSTANCE: method involves the intravenous administration of preparation cytomack at dose 0.5-1.0 ml 0.25% solution per 1 kg child body mass, every day for the first postnatal life days. EFFECT: improved myocardium contractility, simplified treatment, elimination of toxic effect.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING POSTHYPOXIC MYOCARDIAL DYSTROPHY IN NEWBORN CHILDREN | 1993 |
|
RU2098095C1 |
| METHOD FOR ADJUSTING CENTRAL HEMODYNAMICS OF NEWBORNS | 1999 |
|
RU2184552C2 |
| TREATMENT METHOD OF POST-HYPOXIC DEFECTS OF VASCULAR SYSTEM OF NEW-BORN CHILDREN | 2008 |
|
RU2368367C1 |
| METHOD OF INFUSION THERAPY OF PREMATURE INFANTS | 0 |
|
SU1611340A1 |
| METHOD OF TREATING POLYCYTHEMIA IN NEWBORNS SUFFERING INTRAUTERINE GROWTH RETARDATION | 2013 |
|
RU2542443C1 |
| METHOD FOR PREDICTING FUNCTIONAL DISORDERS IN CARDIO-VASCULAR SYSTEM IN NEONATALS OUT OF THE GROUP OF PERINATAL RISK | 2001 |
|
RU2235508C2 |
| METHOD OF EVALUATING VERSIONS OF MYOCARDIUM REMODELLING IN NEWBORN BABIES FROM PERINATAL RISK GROUP | 2009 |
|
RU2419094C1 |
| MEHTOD FOR CARDIOVASCULAR PATHOLOGY PREDICTION IN NEWBORNS OF WOMEN WITH PRE-ECLAMPSIA | 2016 |
|
RU2625745C1 |
| WAY OF DIAGNOSTICS OF DEGREE OF DISTURBANCE OF CARDIOVASCULAR SYSTEM FUNCTION AT NEWBORNS FROM GROUP WITH HIGH PERINATAL RISK | 2007 |
|
RU2363000C2 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF MYOCARDIUM DAMAGE IN NEWBORNS | 1994 |
|
RU2089900C1 |
